Sarepta Therapeutics (SRPT) Free Cash Flow Growth (3y) (2013 - 2026)
Sarepta Therapeutics (SRPT) Free Cash Flow Growth (3y) (2013 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
24.91% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
20.11% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
14.71% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Sarepta Therapeutics |
1.84 Bn |
1.16 Bn |
291.52 Mn |
2.20% |
| Date | Value |
|---|
| Mar 31, 2026 |
2.20% |
| Dec 31, 2025 |
48.45% |
| Sep 30, 2025 |
19.97% |
| Jun 30, 2025 |
71.28% |
| Mar 31, 2025 |
-80.45% |
| Dec 31, 2024 |
54.83% |
| Sep 30, 2024 |
6.85% |
| Jun 30, 2024 |
50.18% |
| Mar 31, 2024 |
-10.85% |
| Dec 31, 2023 |
28.68% |
| Sep 30, 2023 |
18.17% |
| Jun 30, 2023 |
-3.40% |
| Mar 31, 2023 |
-33.02% |
| Dec 31, 2022 |
17.86% |
| Sep 30, 2022 |
1.62% |
| Jun 30, 2022 |
7.43% |
| Mar 31, 2022 |
13.08% |
| Dec 31, 2021 |
39.53% |
| Sep 30, 2021 |
-0.04% |
| Jun 30, 2021 |
2.98% |
